Question 1

What is the purpose of using the 68Ga-ABY-025 PET in my treatment?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer clinical trial (NCT03655353). Contact the study team or your healthcare provider for specific answers.

Question 2

How will the results from this PET scan affect my treatment options?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer clinical trial (NCT03655353). Contact the study team or your healthcare provider for specific answers.

Question 3

What are the potential risks or side effects of participating in this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer clinical trial (NCT03655353). Contact the study team or your healthcare provider for specific answers.

Question 4

How often will I need to come in for visits if I participate?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer clinical trial (NCT03655353). Contact the study team or your healthcare provider for specific answers.

Question 5

What happens if I don't qualify for this trial?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the A Study of 68Ga-ABY-025 PET for Non-invasive Quantification of HER2-expression in Advanced Breast Cancer clinical trial (NCT03655353). Contact the study team or your healthcare provider for specific answers.

What this study is about